Scarica l'app Stockscreener
12.03
2.38%
0.28
Dopo l'orario di chiusura:
12.00
-0.03
-0.25%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Rocket Pharmaceuticals Inc Borsa (RCKT) Ultime notizie
Rocket Pharmaceuticals (NASDAQ:RCKT) Now Covered by Analysts at Wedbush - Defense World
Rocket Pharmaceuticals' SWOT analysis: gene therapy stock poised for growth - Investing.com Canada
Rocket Pharmaceuticals (NASDAQ:RCKT) Now Covered by Wedbush - MarketBeat
Rocket Pharmaceuticals, Inc. (RCKT): Is This Gene Therapy Stock a Good Buy Right Now? - Yahoo Finance
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Rating of “Moderate Buy” by Analysts - Defense World
10 Best Gene Therapy Stocks to Buy Right Now - Insider Monkey
(RCKT) On The My Stocks Page - Stock Traders Daily
Geode Capital Management LLC Boosts Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Position Decreased by HighTower Advisors LLC - Defense World
Rocket Pharmaceuticals Stock Soars as Jefferies Initiates Coverage at 'Buy' - MSN
Rocket Pharmaceuticals (NASDAQ:RCKT) Sets New 1-Year LowHere's Why - MarketBeat
State Street Corp Buys 322,156 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Franklin Resources Inc. Cuts Stock Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
State Street Corp Has $57.29 Million Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
Rocket Pharmaceuticals' SWOT analysis: gene therapy stock faces pivotal year - Investing.com
Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap UpShould You Buy? - MarketBeat
Rocket Pharmaceuticals (NASDAQ:RCKT) Now Covered by Jefferies Financial Group - MarketBeat
Head-To-Head Review: InMed Pharmaceuticals (NASDAQ:INM) & Rocket Pharmaceuticals (NASDAQ:RCKT) - Defense World
RTW INVESTMENTS, LP Increases Stake in Rocket Pharmaceuticals Inc - GuruFocus.com
(RCKT) Trading Report - Stock Traders Daily
Synovus Financial Corp Decreases Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
Leerink Partnrs Has Positive Outlook of RCKT FY2024 Earnings - MarketBeat
FY2024 Earnings Estimate for RCKT Issued By Leerink Partnrs - Defense World
Rocket Pharmaceuticals' SWOT analysis: gene therapy stock poised for growth amid challenges - Investing.com Australia
Rocket Pharmaceuticals' SWOT analysis: gene therapy stock poised for growth amid challenges By Investing.com - Investing.com South Africa
Rocket Pharmaceuticals (NASDAQ:RCKT) Hits New 1-Year LowHere's What Happened - MarketBeat
Rocket Pharmaceuticals completes $178.1 million offering - Investing.com India
Rocket Pharma Stock Slips Despite New Long-Term Data On Phase-I Study; Retail Sentiment Slides - MSN
Rocket Pharmaceuticals completes $178.1 million offering By Investing.com - Investing.com Australia
RSI Alert: Rocket Pharmaceuticals (RCKT) Now Oversold - Nasdaq
RCKT Stock Hits 52-Week Low at $12.62 Amid Market Challenges - Investing.com India
RCKT Stock Hits 52-Week Low at $12.62 Amid Market Challenges By Investing.com - Investing.com South Africa
Fmr LLC Lowers Stock Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
Rocket Pharmaceuticals sets $12.50 share price for offering By Investing.com - Investing.com South Africa
Watkins Advises on Rocket Pharmaceuticals’ Upsized Public Offering of Common Stock - Latham & Watkins LLP
Rocket Pharmaceuticals sets $12.50 share price for offering - Investing.com India
Rocket Pharmaceuticals Secures $165M Through Upsized Public Stock Offering at $12.50 Per Share - StockTitan
Rocket Pharmaceuticals plans $150 million stock offering By Investing.com - Investing.com Canada
Point72 Asset Management L.P. Acquires Shares of 48,096 Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
Rocket Pharmaceuticals plans $150 million stock offering - Investing.com India
Rocket Pharmaceuticals Plans $150 Million Public Offering of Common Shares - Marketscreener.com
Rocket Pharmaceuticals Launches $150M Public Offering to Advance Genetic Therapy Pipeline - StockTitan
Frazier Life Sciences Management L.P. Sells 75,600 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
Wellington Management Group LLP Acquires 2,086,424 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
Janus Henderson Group PLC Has $35.06 Million Stock Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
(RCKT) Investment Report - Stock Traders Daily
44,700 Shares in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Purchased by Erste Asset Management GmbH - MarketBeat
Walleye Capital LLC Buys New Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Rocket Pharmaceuticals Offers Huge Potential as Price Targets Exceed 300% Growth - TheStreet
Bamco Inc. NY Sells 94,990 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
Rocket Pharmaceuticals: Not Bad Valuation But Reflexivity Risks Remain (RCKT) - Seeking Alpha
1.76%
1.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):